Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Total Liabilities (2016 - 2026)

Trafalgar International (GCAN) posted Total Liabilities of $776464.0 for Q1 2026, up 4.58% on a QoQ basis from $742464.0 in Q4 2025, and down 23.05% year-over-year from $1.0 million in Q1 2025.

Analysis

Trafalgar International (GCAN) Total Liabilities (2016 - 2026) Analysis & Trends

Trafalgar International has reported Total Liabilities for 11 years, with the latest figure at $776464.0 in Q1 2026.

  • On a quarterly basis, Total Liabilities fell 23.05% year-over-year to $776464.0 in Q1 2026; TTM through Mar 2026 was $776464.0, a 23.05% decrease from a year earlier, with the FY2025 full-year figure at $742464.0, down 17.33% from the prior year.
  • Total Liabilities was $776464.0 for Q1 2026 at Trafalgar International, up from $742464.0 in the prior quarter.
  • The five-year high for Total Liabilities was $1.1 million in Q3 2025, with the low at $742464.0 in Q4 2025.
  • Average Total Liabilities over 5 years is $897704.7, with a median of $860874.0 recorded in 2024.
  • The sharpest annual moves came in 2022 and 2026: Total Liabilities surged 44.13% in 2022, then slipped 23.05% in 2026.
  • Over 5 years, Total Liabilities stood at $825277.0 in 2022, then climbed by 1.0% to $833508.0 in 2023, then climbed by 7.74% to $898058.0 in 2024, then declined by 17.33% to $742464.0 in 2025, then rose by 4.58% to $776464.0 in 2026.
  • The last three Total Liabilities figures came in at $776464.0 (Q1 2026), $742464.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 116.09 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 141.05 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 23.74 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 80.09 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 115.64 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 69.15 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 1.72 Bn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 1.53 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 819.80 Mn
10 Trafalgar International 217,335.05 217,335.05 - 776,464.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 776,464.00
Dec 31, 2025 742,464.00
Sep 30, 2025 1.13 Mn
Jun 30, 2025 1.10 Mn
Mar 31, 2025 1.01 Mn
Dec 31, 2024 898,058.00
Sep 30, 2024 860,874.00
Jun 30, 2024 833,993.00
Mar 31, 2024 839,333.00
Dec 31, 2023 833,508.00
Sep 30, 2023 856,570.00
Jun 30, 2023 881,605.00
Mar 31, 2023 848,618.00
Dec 31, 2022 825,277.00
Sep 30, 2022 862,190.00
Jun 30, 2022 965,767.00
Mar 31, 2022 998,504.00
Dec 31, 2021 861,999.00
Sep 30, 2021 782,506.00
Jun 30, 2021 670,049.00